Cabot (CBT)
(Delayed Data from NYSE)
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Cabot Inaugurates Carbon Black Expansion Project in Indonesia
by Zacks Equity Research
Cabot's (CBT) capacity expansion project in Indonesia is part of a broader global capacity expansion and debottlenecking project.
Cabot (CBT) Earnings and Sales Fall Short Of Estimates in Q4
by Zacks Equity Research
Cabot (CBT) witnesses weakness in the China business and global automobile production in fourth-quarter fiscal 2019.
Cabot's New TECHBLAK 85 Series to Meet Sustainability Needs
by Zacks Equity Research
Cabot (CBT) unveils new black masterbatch series, designed to minimize industry's carbon footprint and advance circular economy of plastic raw materials.
Cabot (CBT) Boosts Advanced Carbon Portfolio With ATHLOS CNS
by Zacks Equity Research
Cabot's (CBT) latest conductive carbon additive, ATHLOS CNS, aims at facilitating easier processing of high-performance plastic applications.
Cabot (CBT) Opens Fumed Silica Manufacturing Plant in China
by Zacks Equity Research
The new facility enables Cabot (CBT) to maintain its leadership and become the largest provider of fumed silica in the Chinese market.
Why Is Cabot (CBT) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Q3 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Cabot (CBT) faces challenges from a weak business environment in China and sustained weakness in automotive production in Q3.
Cabot (CBT) Matches Q3 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 0.00% and -2.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot Concludes Divestment of Specialty Fluids Business
by Zacks Equity Research
The deal enables Cabot (CBT) to focus on growth opportunities in core businesses.
Why Is Cabot (CBT) Down 7.6% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for June 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for May 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for May 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Cabot Corporation (CBT)
by Brian Bolan
A beat isn't that sweet if it comes with lower guidance
New Strong Sell Stocks for May 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cabot's (CBT) Earnings Beat, Revenues Miss Estimates in Q2
by Zacks Equity Research
Cabot (CBT) faced challenges from pricing weakness in China, weak automotive demand and higher raw material costs in Q2.
Cabot (CBT) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 1.02% and -6.84%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Cabot (CBT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Cabot (CBT) Up 7.8% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Q1 Earnings Miss, Sales Surpass Estimates
by Zacks Equity Research
Cabot's (CBT) performance in Q1 hurt by weaker environment in China along with softer automotive demand and customer inventory destocking. The company lowers adjusted EPS view for fiscal 2019.
Cabot (CBT) Q1 Earnings Miss Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -3.33% and 5.47%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Cabot (CBT) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if Cabot Corporation (CBT) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.